Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer

IMAGE: Christopher Sweeney, MBBS of Dana-Farber Cancer Institute’s Lank Center for Genitourinary Oncology. view more  Credit: Dana-Farber Cancer Institute After 3 years, 80% of men with metastatic hormone-sensitive prostate cancer who received enzalutamide along with testosterone suppression were alive compared to 72% of men who received standard care. Chicago – Enzalutamide, an oral androgen receptor inhibitor,…

Details

Happy Global Running Day

Welcome to the Running newsletter! Every Saturday morning, we email runners with news, advice and some motivation to help you get up and running. Sign up here to get it in your inbox. This Wednesday, June 5, is Global Running Day. Is it a made-up holiday? Sort of. But unlike many made-up holidays dedicated to…

Details

A Golf Lesson With Bridget Moynahan

Bridget Moynahan doesn’t understand people who don’t understand the appeal of watching golf. “I don’t think it’s boring,” said Ms. Moynahan, 48, a star of the police drama “Blue Bloods,” which was just renewed for a 10th season. “I find it really relaxing.” But when it comes to playing golf, relaxing is not quite the…

Details